Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and (Nasdaq: BIIB, Corporate headquarters: Cambridge, ...
BULGOLD Discovers Epithermal Quartz Veins at Surface Within the Sinter Field on the Lutila Gold Project and Completes 2024 Drilling Programme
TORONTO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that it has ...